当前位置: 首页 > 期刊 > 《中国实用医药》 > 2011年第24期
编号:12133916
骨髓间充质干细胞对难治性肺疾病治疗的研究进展(2)
http://www.100md.com 2011年8月25日 《中国实用医药》 2011年第24期
     [3] 赵峰,李圣青,遆新宇,等.骨髓间充质干细胞对肺损伤大鼠转化生长因子β及单核细胞趋化蛋白1的影响.中国组织工程研究与临床康复, 2008,12(29):5627-5630.

    [4] Yamada M, Kubo H, Kobayashi S, et al.Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. Immunol,2004,172(2):1266.

    [5] Salingcarnboriboon R, Yoshitake H, Tsuji K, et al. Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property. Exp Cell Res, 2003, 87:289-300.

    [6] Kilroy GE,Foster SJ,Wu X,et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic,hematopoietic,and pro-inflammatory factors.Cell Physiol,2007,212:702-709.

    [7] Schinkothe T,Bloch W, Schmidt A. In vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev, 2008, 17:199-206.

    [8] Hashimoto N, Jin H, Liu T, et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest, 2004, 113(2):243-252.

    [9] Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282(5391): 1145-1147., http://www.100md.com(尉进茜 伊慧珍)
上一页1 2